The Influence of Chronic Hepatitis C on Atherosclerosis Progression
Lopatkina, T.N.; Strizhakov, L.A.; Tanashchuk, E.L.; Konysheva, A.A.; Moiseev, S.V.
Klinicheskaia Meditsina 93(2): 9-13
2015
ISSN/ISBN: 0023-2149 PMID: 26117913 Document Number: 682791
We analysed the data of domestic andforeign authors on the relationship between hepatitis C and atherosclerosis. The possible role of the former condition as a risk factor of atherosclerosis even in very young patients is due to the properties of hepatitis C virus, mediators of inflammation, and metabolic disorders.
Document emailed within 1 workday
Related Documents
Korba, B.E.; Cote, P.J.; Menne, S.; Toshkov, I.; Baldwin, B.H.; Wells, F.V.; Tennant, B.C.; Gerin, J.L. 2004: Clevudine therapy with vaccine inhibits progression of chronic hepatitis and delays onset of hepatocellular carcinoma in chronic woodchuck hepatitis virus infection Antiviral Therapy 9(6): 937-952Wright, R. 1980: Type B hepatitis: progression to chronic hepatitis Clinics in Gastroenterology 9(1): 97-115
Tassopoulos, N.C.; Papatheodoridis, G.V.; Katsoulidou, A.; Delladetsima, J.K.; Sypsa, V.; Touloumi, G.; Nikandros, M.; Hatzakis, A. 1998: Factors associated with severity and disease progression in chronic hepatitis C Hepato-Gastroenterology 45(23): 1678-1683
Pol, S.; Corouge, M.; Mallet, V.; Sogni, P. 2013: Rapid progression of antiviral treatments of chronic hepatitis C virus infection Minerva Gastroenterologica E Dietologica 59(2): 161-172
Tsuji, K.; Hasebe, C.; Murazumi, Y.; Yosida, Y.; Kanai, M.; Ohta, H.; Ohhira, M.; Kohda, H.; Ono, M.; Yazaki, Y. 1991: A case of type B chronic hepatitis showing rapid progression to liver cirrhosis with prolonged positive IgM anti-HBc Hokkaido Journal of Medical Science 66(4): 575-581
Schoeman, M.N.; Liddle, C.; Bilous, M.; Grierson, J.; Craig, P.I.; Batey, R.G.; Farrell, G.C. 1990: Chronic non-A, non-B hepatitis: lack of correlation between biochemical and morphological activity, and effects of immunosuppressive therapy on disease progression Australian and New Zealand Journal of Medicine 20(1): 56-62
Du, J.; Tian, P.; Chen, T.-y.; Wu, J.-x.; Wang, J.-b.; Wei, Y.; Wang, L.-m.; Liu, L.-g.; Ji, W.-s.; Qu, C.-f. 2011: Progressive increase of serum circulating immune complexes and its significance in patients during the progression from chronic hepatitis B to hepatocellular carcinoma Zhonghua Zhong Liu Za Zhi 33(12): 905-910
Macías, J.; Mira, J.é A.; López-Cortés, L.F.; Santos, I.; Girón-González, J.é A.; González-Serrano, M.; Merino, D.; Hernández-Quero, J.é; Rivero, A.; Merchante, N.ás.; Trastoy, M.ón.; Carrillo-Gómez, R.; Arizcorreta-Yarza, A.; Gómez-Mateos, J.ús.; Pineda, J.A. 2006: Antiretroviral therapy based on protease inhibitors as a protective factor against liver fibrosis progression in patients with chronic hepatitis C Antiviral Therapy 11(7): 839-846
Massabayeva, M.R.; Aukenov, N.E.; Mussazhanova, Z.B.; Saenko, V.A.; Rogounovitch, T.I.; Shaimardanov, N.K.; Kurmanova, B.R.; Barkibaeva, N.R.; Rakhypbekov, T.K. 2016: IL17A gene polymorphisms: relationship to predisposition for chronic viral hepatitis and progression to liver cirrhosis in kazakh population Voprosy Virusologii 61(5): 212-219
Schultz, E. 1998: Tobacco smoke and atherosclerosis progression JAMA 280(1): 33
Bruschke, A.V.; Jukema, J.W.; Van der Wall, E.E. 1993: Progression and regression of coronary atherosclerosis Indian Heart Journal 45(4): 259-264
Seidel, D. 1995: Impact of lipids on progression and regression of atherosclerosis Transplantation Proceedings 27(3): 2057-2061
Hodis, H.N.; Mack, W.J. 1998: Triglyceride-rich lipoproteins and progression of atherosclerosis European Heart Journal 19(Suppl): A40-A44
Tangpradabkiet, W.; Praneenararat, S.; Chamroonkul, N.; Witeerungrot, T.; Piratvisuth, T. 2014: Influence of meal intake on liver stiffness in patients with chronic hepatitis B and C Journal of the Medical Association of Thailand 97(10): 1033-1039
Lewandowska, D.; Durlik, M.; Pazik, J.; Lewandowski, Z.; Lao, M.ła. 2003: The influence of lamivudine therapy on the course of chronic hepatitis B in renal allograft recipients Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 15(88): 367-370
Brzósko, S.; Hryszko, T.; Małyszko, J.; Myśliwiec, M. 2001: Homocysteine--new risk factor for progression of atherosclerosis and its complications Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 10(55): 56-59
Aggarwal, R.A.; Kansal, V.K. 1992: Effect of skim milk on progression of atherosclerosis in cholesterol-fed rabbits Indian Journal of Medical Research 96: 53-59
Caredda, F.; Antinori, S.; Coppin, P.; Parravicini, C.; Vago, L.; Moroni, M. 1991: The influence of human immunodeficiency virus infection on acute and chronic HBsAg-positive hepatitis Progress in Clinical and Biological Research 364: 365-375
Knura, M.ło.; Dragon, J.; Łabuzek, K.; Okopień, B.ła. 2018: The impact of electronic cigarettes usage on the endothelial function and the progression of atherosclerosis Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 44(259): 26-30
Endo, J.; Arita, M. 2011: Roles of lipid mediators in controlling vascular inflammation and the progression of atherosclerosis Nihon Rinsho. Japanese Journal of Clinical Medicine 69(1): 34-38